Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription

Experimental Cell Research

Volumn 305, Issue 2, 2005, Pages 300-311

  Endoh, Teruo ^a   Tsuji, Naoki ^a   Asanuma, Koichi ^a   Yagihashi, Atsuhito ^a   Watanabe, Naoki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

c Myc; Colon cancer cells; Human telomerase reverse transcriptase (hTERT); Phosphatidylinositol 3 kinase (PI3 kinase); Specificity protein 1 (Sp1); Survivin; Telomerase

Indexed keywords

PROTEIN SUBUNIT; SERINE; SMALL INTERFERING RNA; SURVIVIN; SYNAPSIN I; TELOMERASE REVERSE TRANSCRIPTASE; THREONINE; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; DNA BINDING; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UPREGULATION;

EID: 16244362679     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.12.014     Document Type: Article

References (55)

1. C.B. Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456 1462
2. P. Saikumar, Z. Dong, V. Mikhailov, M. Denton, J.M. Weinberg, and M.A. Venkatachalam Apoptosis: definition, mechanisms, and relevance to disease Am. J. Med. 107 1999 489 506
3. M. Jaattela Escaping cell death: survival proteins in cancer Exp. Cell Res. 248 1999 30 43
4. I. Tamm, Y. Wang, E. Sausville, D.A. Scudiero, N. Vigna, T. Oltersdorf, and J.C. Reed IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs Cancer Res. 58 1998 5315 5320
5. S. Shin, B.J. Sung, Y.S. Cho, H.J. Kim, N.C. Ha, J.I. Hwang, C.W Chung, Y.K. Jung, and B.H. Oh An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7 Biochemistry 40 2001 1117 1123
6. K. Asanuma, R. Moriai, T. Yajima, A. Yagihashi, M. Yamada, D. Kobayashi, and N. Watanabe Survivin as a radioresistance factor in pancreatic cancer Jpn. J. Cancer Res. 91 2000 1204 1209
7. K. Asanuma, D. Kobayashi, D. Furuya, N. Tsuji, A. Yagihashi, and N. Watanabe A role for survivin in radioresistance of pancreatic cancer cells Jpn. J. Cancer Res. 93 2002 1057 1062
8. K. Tanaka, S. Iwamoto, G.. Gon, T. Nohara, M. Iwamoto, and N. Tanigawa Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin. Cancer Res. 6 2000 127 134
9. J. Kato, Y. Kuwabara, M. Mitani, N. Shinoda, A. Sato, T. Toyama, A. Mitsui, T. Nishiwaki, S. Moriyama, J. Kudo, and Y. Fujii Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy Int. J. Cancer 95 2001 92 95
10. C.D. Lu, D.C. Altieri, and N. Tanigawa Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas Cancer Res. 58 1998 1808 1812
11. M. Nakamura, N. Tsuji, K. Asanuma, D. Kobayashi, A. Yagihashi, K. Hirata, T. Torigoe, N. Sato, and N. Watanabe Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients Cancer Sci. 95 2004 44 51
12. K. Satoh, K. Kaneko, M. Hirota, A. Masamune, A. Satoh, and T. Shimosegawa Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors Cancer 92 2001 271 278
13. H. Kawasaki, D.C. Altieri, C.D. Lu, M. Toyoda, T. Tenjo, and N. Tanigawa Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer Cancer Res. 58 1998 5071 5074
14. A.I. Sarela, R.C. Macadam, S.M. Farmery, A.F. Markham, and P.J. Guillou Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma Gut 46 2000 645 650
15. R.K. Moyzis, J.M. Buckingham, L.S. Cram, M. Dani, L.L. Deaven, M.D. Jones, J. Meyne, R.L. Ratliff, and J.R. Wu A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes Proc. Natl. Acad. Sci. U. S. A. 85 1988 6622 6626
16. T. de Lange, L. Shiue, R.M. Myers, D.R. Cox, S.L. Naylor, A.M. Killery, and H.E. Varmus Structure and variability of human chromosome ends Mol. Cell. Biol. 10 1990 518 527
17. V.L. Makarov, Y. Hirose, and J.P. Langmore Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening Cell 88 1997 657 666
18. K.E. Huffman, S.D. Levene, V.M. Tesmer, J.W. Shay, and W.E. Wright Telomere shortening is proportional to the size of the G-rich telomeric 3′-overhang J. Biol. Chem. 275 2000 19719 19722
19. K. Dhaene, E. Van Marck, and R. Parwaresch Telomeres, telomerase and cancer: an up-date Virchows Arch. 437 2000 1 16
20. E. Hiyama, T. Yokoyama, N. Tatsumoto, K. Hiyama, Y. Imamura, Y. Murakami, T. Kodama, M.A. Piatyszek, J.W. Shay, and Y. Matsuura Telomerase activity in gastric cancer Cancer Res. 55 1995 3258 3262
21. C. Chadeneau, K. Hay, H.W. Hirte, S. Gallinger, and S. Bacchetti Telomerase activity associated with acquisition of malignancy in human colorectal cancer Cancer Res. 55 1995 2533 2536
22. A.G. Bodnar, M. Ouellette, M. Frolkis, S.E. Holt, C.P. Chiu, G.B. Morin, C.B. Harley, J.W. Shay, S. Lichtsteiner, and W.E. Wright Extension of life-span by introduction of telomerase into normal human cells Science 279 1998 349 352
23. H. Vaziri, and S. Benchimol Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span Curr. Biol. 8 1998 279 282
24. A.K. Meeker, and A.M. De Marzo Recent advances in telomere biology: implications for human cancer Curr. Opin. Oncol. 16 2004 32 38
25. C.P. Morales, S.E. Holt, M. Ouellette, K.J. Kaur, Y. Yan, K.S. Wilson, M.A. White, W.E. Wright, and J.W. Shay Absence of cancer-associated changes in human fibroblasts immortalized with telomerase Nat. Genet. 21 1999 115 118
26. W.C. Hahn, S.A. Stewart, M.W. Brooks, S.G. York, E. Eaton, A. Kurachi, R.L. Beijersbergen, J.H. Knoll, M. Meyerson, and R.A. Weinberg Inhibition of telomerase limits the growth of human cancer cells Nat. Med. 5 1999 1164 1170
27. F. Delhommeau, A. Thierry, D. Feneux, E. Lauret, E. Leclercq, M.H. Courtier, F. Sainteny, W. Vainchenker, and A. Bennaceur-Griscelli Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant Oncogene 21 2002 8262 8271
28. S. Ramakrishnan, U. Eppenberger, H. Mueller, Y. Shinkai, and R. Narayanan Expression profile of the putative catalytic subunit of the telomerase gene Cancer Res. 58 1998 622 625
29. K. Asanuma, N. Tsuji, T. Endoh, A. Yagihashi, and N. Watanabe Survivin enhances Fas ligand expression via up-regulation of Sp1-mediated gene transcription in colon cancer cells J. Immunol. 172 2004 3922 3929
30. C. Mahotka, M. Wenzel, E. Springer, H.E. Gabbert, and C.D. Gerharz Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties Cancer Res. 59 1999 6097 6102
31. N. Tsuji, C. Kamagata, M. Furuya, D. Kobayashi, A. Yagihashi, T. Morita, S. Horita, and N. Watanabe Selection of an internal control gene for quantitation of mRNA in colonic tissues Anticancer Res. 22 2002 4173 4178
32. H.A. Lehr, D.A. Mankoff, D. Corwin, G. Santeusanio, and A.M. Gown Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer J. Histochem. Cytochem. 45 1997 1559 1565
33. H.A. Lehr, C.M. van der Loos, P. Teeling, and A.M. Gown Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis J. Histochem. Cytochem. 47 1999 119 125
34. P. Grabowski, T. Kuhnel, F. Muhr-Wilkenshoff, B. Heine, H. Stein, M. Hopfner, C.T. Germer, and H. Scherubl Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma Br. J. Cancer 88 2003 115 119
35. S. Kyo, M. Takakura, T. Taira, T. Kanaya, H. Itoh, M. Yutsudo, H. Ariga, and M. Inoue Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT) Nucleic Acids Res. 28 2000 669 677
36. M.M. Kavurma, F.S. Santiago, E. Bonfoco, and L.M. Khachigian Sp1 phosphorylation regulates apoptosis via extracellular FasL-Fas engagement J. Biol. Chem. 276 2001 4964 4971
37. X. Ye, and S.F. Liu Lipopolysaccharide down-regulates Sp1 binding activity by promoting Sp1 protein dephosphorylation and degradation J. Biol. Chem. 277 2002 31863 31870
38. S. Gupta, A. Seth, and R.J. Davis Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62 Proc. Natl. Acad. Sci. U. S. A. 90 1993 3216 3220
39. S.P. Jackson, J.J. MacDonald, S. Lees-Miller, and R. Tjian GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase Cell 63 1990 155 165
40. C. Rohlff, S. Ahmad, F. Borellini, J. Lei, and R.I. Glazer Modulation of transcription factor Sp1 by cAMP-dependent protein kinase J. Biol. Chem. 272 1997 21137 21141
41. S. Pal, K.P. Claffey, H.T. Cohen, and D. Mukhopadhyay Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta J. Biol. Chem. 273 1998 26277 26280
42. A. Seth, E. Alvarez, S. Gupta, and R.J. Davis A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression J. Biol. Chem. 266 1991 23521 23524
43. K. Saksela, T.P. Makela, K. Hughes, J.R. Woodgett, and K. Alitalo Activation of protein kinase C increases phosphorylation of the L-myc trans-activator domain at a GSK-3 target site Oncogene 7 1992 347 353
44. R.S. Watnick, Y.N. Cheng, A. Rangarajan, T.A. Ince, and R.A. Weinberg Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis Cancer Cells 3 2003 219 231
45. K. Reisinger, R. Kaufmann, and J. Gille Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription J. Cell Sci. 116 2003 225 238
46. P. Rodriguez-Viciana, P.H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M.J. Fry, M.D. Waterfield, and J. Downward Phosphatidylinositol-3-OH kinase as a direct target of Ras Nature 370 1994 527 532
47. B. Tocque, I. Delumeau, F. Parker, F. Maurier, M.C. Multon, and F. Schweighoffer Ras-GTPase activating protein (GAP): a putative effector for Ras Cell Signalling 9 1997 153 158
48. V. Leblanc, I. Delumeau, and B. Tocque Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells Oncogene 18 1999 4884 4889
49. V. Gigoux, S. L'Hoste, F. Raynaud, J. Camonis, and C. Garbay Identification of Aurora kinases as RasGAP Src homology 3 domain-binding proteins J. Biol. Chem. 277 2002 23742 23746
50. M.A. Bolton, W. Lan, S.E. Powers, M.L. McCleland, J. Kuang, and P.T. Stukenberg Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation Mol. Biol. Cell 13 2002 3064 3077
51. J. Chen, S. Jin, S.K. Tahir, H. Zhang, X. Liu, A.V. Sarthy, P.T. McGonigal, Z. Liu, S.H. Rosenberg, and S.C. Ng Survivin enhances aurora-B kinase activity and localizes aurora-B in human cells J. Biol. Chem. 278 2003 486 490
52. D. Kagi, F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity Science 265 1994 528 530
53. G. Berke The CTL's kiss of death Cell 81 1995 9 12
54. K. Shiraki, N. Tsuji, T. Shioda, K.J. Isselbacher, and H. Takahashi Expression of Fas ligand in liver metastases of human colonic adenocarcinomas Proc. Natl. Acad. Sci. U. S. A. 94 1997 6420 6425
55. J. O'Connell, G.C. O'Sullivan, J.K. Collins, and F. Shanahan The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand J. Exp. Med. 184 1996 1075 1082